Company Code: 6794 Company Name: Syngen Biotech Industry: Biotechnology & Medical Care Data for: 2026-02 Monthly Revenue: 2,630 thousand NTD (0.03 billion) Year-over-Year Change: +186.2%
FACT BOX
- Source: PR Times
- Category: 調查
調查
【Syngen Biotech】February 2026 Revenue: 0.03 Billion (YoY +186.2%)
Citation-Grade
Primary-source linked
Schema.org verified
NQ 63 / 100
Published Feb 1, 2026 9:00 AM ・ Updated Jun 1, 2026 12:17 PM ・ 2 min read ・ Source: PR Times
Show contents
⚡ Key Points
- Syngen Biotech (6794) has released its financial report for February 2026.
- The company's revenue for the month was 2,630 thousand NTD (0.03 billion NTD), an increase of 186.2% compared to the same period last year.
- Syngen Biotech is a company specializing in the biotechnology and healthcare industry.
Syngen Biotech (6794) has released its financial report for February 2026. The company's revenue for the month was 2,630 thousand NTD (0.03 billion NTD), an increase of 186.2% compared to the same period last year. Syngen Biotech is a company specializing in the biotechnology and healthcare industry.
Editorial & Verification Standards
The Washin AI News desk structures and reviews this article under the following standards.
- Start only from primary sources (official PR, disclosures, wire services)
- Numbers and proper nouns machine-checked against the source (number-completeness check)
- Company names and tickers verified via registry (Registry/TWSE/Wikidata)
- No speculation; nothing stated that is not in the source
Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›
- Announced Feb 1, 2026 9:00 AM — Distributor PR Times
- Collected Apr 7, 2026 8:00 AM
- AI structured & analyzed Apr 8, 2026 12:19 AM
- Desk-reviewed & published Feb 1, 2026 9:00 AM
FAQ
What are the key facts in this article?
Syngen Biotech (6794) has released its financial report for February 2026. The company's revenue for the month was 2,630 thousand NTD (0.03 billion NTD), an increase of 186.2% compared to the same period last year. Syngen Biotech is a company specializing in the biotechnology and healthcare industry.
Where is the primary source?
PR Times: https://openapi.twse.com.tw/revenue/twse-rev-6794-11502
When was it published?
Feb 1, 2026
Cite this article — HOW TO CITE
Washin AI News Desk“【Syngen Biotech】February 2026 Revenue: 0.03 Billion (YoY +186.2%)”AI News by Washin Village（和心村）, Feb 1, 2026. https://aeo.washinmura.jp/ai/%E5%90%91%E6%A6%AE%E7%94%9F%E6%8A%80/en/news/2026-02-01-syngen-biotech-february-2026-revenue-0-0
AI CRAWLER ACTIVITY
as of Jul 17, 2026
AI crawler visits to this article (cumulative)182 bots
Site-wide cumulative
Applebot
bot_visits_summary
4131k
last Jul 17, 2026
ClaudeBot
bot_visits_summary
3022k
last Jul 17, 2026
GPTBot
bot_visits_summary
2583k
last Jul 17, 2026
Bingbot
bot_visits_summary
2448k
last Jul 17, 2026
Meta AI
bot_visits_summary
1011k
last Jul 17, 2026
Google AI
bot_visits_summary
687k
last Jul 17, 2026
※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.
Washin AI News（AI News by Washin Village（和心村））
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.
Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification
Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →